Leaps by Bayer — 2024 Investments
4 investments dated 2024 · listed companies and verified rows first · show all
NextPoint is a precision therapeutics company developing cancer treatments targeting the B7-H7/HHLA2 axis, including a T-cell engager, an antibody-drug conjugate with proprietary linker technology, and a multi-functional checkpoint inhibitor.
BiotechHealthtechAustin, US
Gordon Freeman(Scientific Founder)XingXing Zang(Scientific Founder)inIvan Cheung(Chief Executive Officer)inLeena Gandhi(Chief Medical Officer)inTatiana Novobrantseva(Chief Scientific Officer)inAxel Hoos(Director)
Co-investorsCatalio Capital Management, LPMPM BioImpactSanofi VenturesCatalio Capital ManagementInvusSixty Degree Capital
Summer Health provides text-based, on-demand pediatric care that connects parents with doctors within minutes for their children's non-scheduled health needs.
ConsumerDigital HealthHealthtech
Co-investors7wire VenturesCoalition OperatorsCorewell Health VenturesIngeborg InvestmentsLux CapitalSequoia Capital+5 more
Transcarent operates a generative AI-powered health and care platform that combines medical, pharmacy, and point solutions to help people navigate the healthcare system and access on-demand care.
AI & Machine LearningDigital HealthHealthtech
Co-investorsAlta PartnersThreshold VenturesAlly Bridge GroupGeneral CatalystGeodesic CapitalHuman Capital+2 more
Transcarent operates a generative AI-powered health and care platform that combines medical, pharmacy, and point solutions into a single member experience, helping people navigate the healthcare system and access on-demand care.
AI & Machine LearningDigital HealthHealthtechDenver, US
Glen Tullman(Founder & CEO)in
Co-investors7wire VenturesCorewell Health VenturesGeneral CatalystGeodesic CapitalGreatPoint VenturesHuman Capital+5 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.